Screener
Pfizer PFE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Pfizer’s reported figures.
The source filing: Pfizer’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000078003-26-000054
FAQ
- What is Pfizer's enterprise value?
- Pfizer (PFE) reported enterprise value of $222.4B in Q1 2026.
- How has Pfizer's enterprise value changed year-over-year?
- Pfizer's enterprise value increased by 9.2% year-over-year, from $203.62B to $222.4B.
- What is the long-term trend for Pfizer's enterprise value?
- Over 5 years (2020 to 2025), Pfizer's enterprise value has grown at a -3.3% compound annual growth rate (CAGR), from $245.35B to $207.64B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Pfizer's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude